Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
105.50
-0.25 (-0.24%)
At close: Aug 29, 2025, 4:00 PM
105.75
+0.25 (0.24%)
After-hours: Aug 29, 2025, 7:52 PM EDT
Boston Scientific Stock Forecast
Stock Price Forecast
The 22 analysts that cover Boston Scientific stock have a consensus rating of "Strong Buy" and an average price target of $118.32, which forecasts a 12.15% increase in the stock price over the next year. The lowest target is $100 and the highest is $135.
Price Target: $118.32 (+12.15%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jul 24, 2025.
Analyst Ratings
The average analyst rating for Boston Scientific stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 12 | 12 | 10 | 10 | 10 |
| Buy | 10 | 10 | 10 | 11 | 11 | 11 |
| Hold | 2 | 1 | 1 | 1 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 23 | 23 | 22 | 23 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $130 → $135 | Strong Buy | Maintains | $130 → $135 | +27.96% | Jul 24, 2025 |
| Raymond James | Raymond James | Strong Buy Maintains $121 → $124 | Strong Buy | Maintains | $121 → $124 | +17.54% | Jul 24, 2025 |
| Oppenheimer | Oppenheimer | Hold Maintains $110 → $118 | Hold | Maintains | $110 → $118 | +11.85% | Jul 24, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $118 → $124 | Buy | Maintains | $118 → $124 | +17.54% | Jul 24, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $120 → $125 | Strong Buy | Maintains | $120 → $125 | +18.48% | Jul 24, 2025 |
Financial Forecast
Revenue This Year
20.06B
from 16.75B
Increased by 19.75%
Revenue Next Year
22.26B
from 20.06B
Increased by 10.98%
EPS This Year
3.01
from 1.25
Increased by 140.98%
EPS Next Year
3.43
from 3.01
Increased by 13.90%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.0B | 23.6B | |||
| Avg | 20.1B | 22.3B | |||
| Low | 19.2B | 21.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 25.5% | 17.6% | |||
| Avg | 19.8% | 11.0% | |||
| Low | 14.8% | 6.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.19 | 3.80 | |||
| Avg | 3.01 | 3.43 | |||
| Low | 2.90 | 3.19 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 155.4% | 26.2% | |||
| Avg | 141.0% | 13.9% | |||
| Low | 132.1% | 5.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.